Sidoti analyst Anthony Lebiedzinski downgraded Prestige Consumer (PBH) to Neutral from Buy with a $90 price target The firm sees limited upside with the shares nearing the price target Further multiple expansion for Prestige may potentially be more limited, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PBH:
- Prestige Consumer price target raised to $93 from $86 at Canaccord
- Prestige Consumer Healthcare Reports Robust Q2 FY25 Results
- Prestige Consumer Healthcare Exceeds Q2 2025 Expectations
- Prestige Consumer reports Q2 EPS $1.09, consensus $1.08
- Prestige Consumer backs FY25 adjusted EPS view $4.40-$4.46, consensus $4.74